These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 876172)

  • 1. [Hypertension in chronic kidney insufficiency in childhood. Significance of renin, aldosterone and blood volume].
    Rauh W; Müller-Wiefel DE; Heide B; Schärer K
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):375-6. PubMed ID: 876172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin-aldosterone system in terminal renal failure.
    Weidmann P; Maxwell MH
    Kidney Int Suppl; 1975 Sep; ():S219-34. PubMed ID: 1104972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renal insufficiency and renin-angiotensin-aldosterone].
    Ishii M; Ikeda T; Yagi S
    Nihon Rinsho; 1974 Mar; 32(3):518-27. PubMed ID: 4368245
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenetic participation of exchangeable sodium and plasma renin activity in the genesis and development of hypertension in patients with chronic renal insufficiency on maintenance dialysis].
    Horký K; Kapitola J; Lachmanová J; Straková M; Tomásek R; Kaslíková J
    Cas Lek Cesk; 1974 Jun; 113(24):732-40. PubMed ID: 4451960
    [No Abstract]   [Full Text] [Related]  

  • 7. A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease.
    Oh MS; Carroll HJ; Clemmons JE; Vagnucci AH; Levison SP; Whang ES
    Metabolism; 1974 Dec; 23(12):1157-66. PubMed ID: 4372510
    [No Abstract]   [Full Text] [Related]  

  • 8. [The renin-angiotensin-aldosterone system under stimulation conditions after kidney transplantation].
    Küppers H; Banzhaf R; Schnurr E
    Med Welt; 1981 Jul; 32(29):1141-2. PubMed ID: 7022102
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension in chronic renal failure.
    Stone WJ
    J Tenn Med Assoc; 1975 Mar; 68(3):204-5. PubMed ID: 1121173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications for bilateral nephrectomy in renal hypertension].
    Weidmann P
    Schweiz Med Wochenschr; 1974 Jul; 104(27):951-8. PubMed ID: 4460233
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
    Bras H; Ochs HG; Armbruster H; Heintz R
    Clin Nephrol; 1976 Feb; 5(2):57-60. PubMed ID: 943254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of renin and electrolyte disorders in the pathogenesis of hypertension in chronic renal insufficiency].
    Charyev M; Vokolova ZP
    Kardiologiia; 1972 Aug; 12(8):22-7. PubMed ID: 4642631
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma aldosterone in patients with end stage kidney disease.
    Weidmann P; Lupu AN; Schroth P; Maxwell MH
    Proc Eur Dial Transplant Assoc; 1972; 9():147-53. PubMed ID: 4668907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyporeninic hypoaldosteronism: pathogenetic importance of kidney parenchyma diseases and age].
    Weidmann P; Maxwell MH; Winer R; Rowe P; Bursztein S; de Lima J
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1805-8. PubMed ID: 4456600
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 3) Change of the renin-angiotensin-aldosterone system after bilateral nephrectomy and kidney transplantation in chronic renal failure (author's transl)].
    Fukuchi S; Nakajima K; Sekino H; Ishizaki M
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):305-13. PubMed ID: 353341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.